Initial biopsy Gleason score as a predictive marker for survival benefit in patients with castration-resistant prostate cancer treated with docetaxel: Data from the tax327 study

Robert J. Van Soest, Ellen S. De Morrée, Liji Shen, Ian F. Tannock, Mario A. Eisenberger, Ronald De Wit

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Initial biopsy Gleason score as a predictive marker for survival benefit in patients with castration-resistant prostate cancer treated with docetaxel: Data from the tax327 study'. Together they form a unique fingerprint.

Medicine & Life Sciences